Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
implant |
| gptkbp:activeIngredient |
gptkb:goserelin
|
| gptkbp:administeredBy |
gptkb:physician
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
gptkb:L02AE03
|
| gptkbp:brand |
gptkb:Zoladex
|
| gptkbp:contraindication |
pregnancy
hypersensitivity to goserelin |
| gptkbp:developedBy |
gptkb:AstraZeneca
|
| gptkbp:duration |
1 month
3 months |
| https://www.w3.org/2000/01/rdf-schema#label |
goserelin implant
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
GnRH agonist
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:regulates |
gonadotropin secretion
|
| gptkbp:routeOfAdministration |
subcutaneous
|
| gptkbp:sideEffect |
decreased libido
mood changes hot flashes erectile dysfunction bone thinning |
| gptkbp:suppressedBy |
testosterone production
estrogen production |
| gptkbp:usedFor |
gptkb:cancer
prostate cancer assisted reproduction endometriosis uterine fibroids |
| gptkbp:bfsParent |
gptkb:Zoladex
|
| gptkbp:bfsLayer |
7
|